Seattle, WA, United States of America

Wayne L Breidford



Average Co-Inventor Count = 6.9

ph-index = 5

Forward Citations = 334(Granted Patents)


Company Filing History:


Years Active: 2008-2014

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Wayne L Breidford: Innovator in Integrated Nucleic Acid Assays

Introduction

Wayne L Breidford, based in Seattle, WA, is an accomplished inventor known for his significant contributions to the field of nucleic acid detection. With five patents to his name, Breidford has been at the forefront of developing technologies that enhance clinical diagnostics.

Latest Patents

Breidford's latest patents revolve around integrated nucleic acid assays. These innovations feature integrated microfluidic cartridges designed for the extraction, amplification, and detection of nucleic acids from clinical samples. The cartridges are characterized by their single-entry design, sanitary features, and disposability, enabling both simplex and multiplex nucleic acid target detection. They can be utilized in various assay panels for detecting multiple infectious agents or identifying cancerous cell types. Furthermore, the patents outline methods for using these microfluidic cartridges within fully automated, pneumatically controlled apparatuses, streamlining the diagnostic process.

Career Highlights

Wayne L Breidford currently works at Micronics, Inc., where he continues to push the boundaries of innovation in medical diagnostics. His expertise in microfluidics and nucleic acid testing has had a profound impact on the development of new diagnostic tools that promise to improve patient outcomes.

Collaborations

Throughout his career, Breidford has worked alongside notable colleagues, including C. Frederick Battrell and Christy A. Lancaster. These collaborations have facilitated the convergence of ideas and innovations, ultimately enhancing the quality and application of their developed technologies.

Conclusion

Wayne L Breidford's commitment to innovation in integrated nucleic acid assays marks him as a significant figure in medical diagnostics. With his ongoing contributions to Micronics, Inc. and a strong portfolio of patents, Breidford is poised to continue making strides in this vital field. His work not only advances technology but also plays a crucial role in improving healthcare efficiency and effectiveness.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…